Vaccinia virus

"Vaccinia virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The type species of ORTHOPOXVIRUS, related to COWPOX VIRUS, but whose true origin is unknown. It has been used as a live vaccine against SMALLPOX. It is also used as a vector for inserting foreign DNA into animals. Rabbitpox virus is a subspecies of VACCINIA VIRUS.

Descriptor ID	D014616
MeSH Number(s)	B04.280.650.160.650.900
Concept/Terms	Vaccinia virus Vaccinia virus Vaccinia viruses Poxvirus officinale Rabbitpox virus Rabbitpox virus Rabbitpox viruses Rabbit Pox Virus Rabbit Pox Viruses Buffalopox virus Buffalopox virus Buffalopox viruses virus, Buffalopox Buffalo Pox Virus Buffalo Pox Viruses Virus, Buffalo Pox Viruses, Buffalo Pox

Below are MeSH descriptors whose meaning is more general than "Vaccinia virus".

Organisms [B]
Viruses [B04]
DNA Viruses [B04.280]
Poxviridae [B04.280.650]
Chordopoxvirinae [B04.280.650.160]
Orthopoxvirus [B04.280.650.160.650]
Vaccinia virus [B04.280.650.160.650.900]

Below are MeSH descriptors whose meaning is related to "Vaccinia virus".

Below are MeSH descriptors whose meaning is more specific than "Vaccinia virus".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vaccinia virus" by people in this website by year, and whether "Vaccinia virus" was a major or minor topic of these publications.

Bar chart showing 54 publications over 22 distinct years, with a maximum of 6 publications in 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	1	0	1
1998	0	2	2
1999	0	2	2
2000	1	0	1
2001	2	0	2
2003	0	1	1
2004	0	1	1
2005	4	1	5
2006	2	0	2
2007	2	2	4
2008	3	2	5
2009	3	2	5
2010	3	3	6
2011	0	1	1
2012	3	1	4
2013	1	2	3
2014	1	1	2
2015	1	1	2
2017	1	0	1
2020	0	1	1
2022	0	1	1
2024	1	1	2

Below are the most recent publications written about "Vaccinia virus" by people in Profiles.

Cua S, Tello BA, Farelo MA, Rodriguez E, Escalante GM, Mutsvunguma LZ, Ogembo JG, Reidel IG. A Novel Monoclonal Antibody Against a Modified Vaccinia Ankara (MVA) Envelope Protein as a Tool for MVA Virus Titration by Flow Cytometry. Viruses. 2024 Oct 17; 16(10).

View in: PubMed
Escalante GM, Reidel IG, Mutsvunguma LZ, Cua S, Tello BA, Rodriguez E, Farelo MA, Zimmerman C, Muniraju M, Li H, Govindan AN, Axthelm MK, Wong SW, Ogembo JG. Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice. Front Immunol. 2024; 15:1445209.

View in: PubMed
Harwood OE, Balgeman AJ, Weaver AJ, Ellis-Connell AL, Weiler AM, Erickson KN, Matschke LM, Golfinos AE, Vezys V, Skinner PJ, Safrit JT, Edlefsen PT, Reynolds MR, Friedrich TC, O'Connor SL. Transient T Cell Expansion, Activation, and Proliferation in Therapeutically Vaccinated Simian Immunodeficiency Virus-Positive Macaques Treated with N-803. J Virol. 2022 12 14; 96(23):e0142422.

View in: PubMed
Riding RL, Richmond JM, Fukuda K, Harris JE. Type I interferon signaling limits viral vector priming of CD8+ T cells during initiation of vitiligo and melanoma immunotherapy. Pigment Cell Melanoma Res. 2021 07; 34(4):683-695.

View in: PubMed
Hatfield SD, Daniels KA, O'Donnell CL, Waggoner SN, Welsh RM. Weak vaccinia virus-induced NK cell regulation of CD4 T cells is associated with reduced NK cell differentiation and cytolytic activity. Virology. 2018 06; 519:131-144.

View in: PubMed
Reeman S, Gates AJ, Pulford DJ, Krieg A, Ulaeto DO. Protection of Mice from Lethal Vaccinia Virus Infection by Vaccinia Virus Protein Subunits with a CpG Adjuvant. Viruses. 2017 12 09; 9(12).

View in: PubMed
Vreven T, Moal IH, Vangone A, Pierce BG, Kastritis PL, Torchala M, Chaleil R, Jim?nez-Garc?a B, Bates PA, Fernandez-Recio J, Bonvin AM, Weng Z. Updates to the Integrated Protein-Protein Interaction Benchmarks: Docking Benchmark Version 5 and Affinity Benchmark Version 2. J Mol Biol. 2015 Sep 25; 427(19):3031-41.

View in: PubMed
Che JW, Selin LK, Welsh RM. Evaluation of non-reciprocal heterologous immunity between unrelated viruses. Virology. 2015 Aug; 482:89-97.

View in: PubMed
Kotwal GJ, Fernando N, Zhou J, Valter K. Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases. Mol Immunol. 2014 Oct; 61(2):204-9.

View in: PubMed
Polykratis A, Hermance N, Zelic M, Roderick J, Kim C, Van TM, Lee TH, Chan FKM, Pasparakis M, Kelliher MA. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J Immunol. 2014 Aug 15; 193(4):1539-1543.

View in: PubMed

People

Explore

Similar Concepts

Top Journals